期刊文献+

阿托伐他汀联合诺和龙对糖尿病肾病的治疗效果 被引量:1

下载PDF
导出
摘要 目的探讨阿托伐他汀与诺和龙联合应用对糖尿病肾病的治疗效果。方法选取2015年3月至2016年1月在肇庆市第一人民医院接受治疗的52例糖尿病肾病患者为研究对象,按照入院顺序分为两组,各26例。对照组患者仅接受诺和龙治疗,观察组患者在对照组患者治疗基础上加用阿托伐他汀治疗,比较两组患者的各临床指标水平。结果治疗前两组患者各指标水平比较,差异无统计学意义(P>0.05);治疗后观察组患者的舒张压、收缩压水平,空腹、餐后2 h血糖水平及糖化血红蛋白和血肌酐水平均低于对照组,差异有统计学意义(P均<0.05)。结论采用阿托伐他汀联合诺和龙治疗糖尿病肾病,能够有效控制患者血压、血糖水平,同时对其肾功能有一定的保护作用,效果确切,值得推广。
出处 《河南医学研究》 CAS 2017年第21期3965-3966,共2页 Henan Medical Research
  • 相关文献

参考文献6

二级参考文献59

  • 1徐贵华,李雁,袁利,谢平,陈永华,赵晋媛.丹参和黄芪注射液联用对慢性肾脏病基础上急性肾损伤的影响[J].中华临床医师杂志(电子版),2011,5(20):5983-5986. 被引量:11
  • 2秦晓丹.阿托伐他汀治疗2型糖尿病早期肾病临床观察[J].临床误诊误治,2011,24(S1):63-64. 被引量:8
  • 3李平,李耀峰.晨尿与随意尿微量清蛋白检测对糖尿病肾损害早期诊断价值[J].检验医学与临床,2007,4(4):280-280. 被引量:11
  • 4NAVARRO J F, MORA C, MACA M, et al. , Inflammatory param- eters are independently associated with urinary albumin in type 2 di- abetes mellitus[J]. Am J Kidney Dis, 2003,42( 1 ) : 53 -61.
  • 5ARIK H O,YALCIN A D, GUMUSLU S, et al. Association of cir- culating strail and high - sensitivity CRP with type 2 diabetic ne- phropathy and foot ulcers [ J ]. Med Sci Monit, 2013,19 : 712 - 715.
  • 6ABRAHAMIAN H, ENDLER G, EXNER M,et al. Association of low- grade inflammation with nephropathy in type 2 diabetic pa- tients: role of elevated CRP - levels and 2 different gene - poly- morphisms of proinflammatory cytokines[J]. Exp Clin Endocrinol Diabetes, 2007,115( 1 ) : 38 -41.
  • 7RAKITIANSKAIA I A, RIABOV S l, DUBROVA A G, et al. The role of IL - 6 in the development of morphological changes in renal tissue in elderly patients with type 2 diabetes complicated by dia- betic nephropathy[J]. Adv Gerontol, 2012,25(4): 632-637.
  • 8ARABABADI M K, REZA MIRZAEI M, ALI SAJADI S M, et al. Interleukin (IL) - 10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran [ J ]. Inflammation, 2012,35 (3) : 797 - 802.
  • 9ATHYROS V G, MIKHAILIDIS D P, PAPAGEORGIOU A A, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analy- sis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study[J]. J Clin Pathol, 2004,57(7) : 728 -734.
  • 10COLHOUN H M, BETTERIDGE D J, DURRINGTON P N,et al. Effects of atorvastatin on kidney outcomes and cardiovascular dis- ease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study ( CARDS ) [ J ]. Am J Kidney Dis, 2009,54(5) : 810 -819.

共引文献98

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部